Aim 1. Discover and Develop Targeted Therapeutics Engaging Key Cancer Pathways. CTT members discover antineoplastic properties of natural and synthetic products, identify new “druggable” targets by integrating high throughput screening approaches with a variety of genetic, transcriptomics, proteomics and metabolomic approaches to develop, refine, or combine compounds that interact with key cancer pathways to address…